Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Rebecca M. Ricklis · SciRah

Researcher profile · Semantic Scholar

Rebecca M. Ricklis

Share profile

Rebecca M. Ricklis — researcher profile on SciRah

h-index: 10
Works: 17
Citations: 857

Most-cited papers

Structure-function analysis of the antioxidant properties of haptoglobin.
M. Melamed-Frank, Orit Lache, Ben Enav, Tal Szafranek +3 more
2001Blood342 citations Open access
Semantic Scholar
Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models
S. Denmeade, Lori J. Sokoll, Susan L. Dalrymple, D. Rosen +4 more
2003The Prostate137 citations
Semantic Scholar
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.
J. Karp, Rebecca M. Ricklis, Kumudha Balakrishnan, Janet Briel +7 more
2007Blood85 citations Open access
Semantic Scholar
Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)‐activated thapsigargin prodrug
Samuel Janssen, D. Rosen, Rebecca M. Ricklis, C. Dionne +4 more
2006The Prostate56 citations
Semantic Scholar
Comparative study of PSMA expression in the prostate of mouse, dog, monkey, and human
S. Aggarwal, Rebecca M. Ricklis, Simon A. Williams, S. Denmeade
2006The Prostate48 citations
Semantic Scholar
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia : a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib ( R 115777 , Zarnestra ) combined with etoposide
J. Karp, K. Flatten, E. Feldman, J. Greer +18 more
200846 citations
Semantic Scholar
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia
J. Lancet, F. Ravandi, Rebecca M. Ricklis, L. Cripe +8 more
2011Leukemia44 citations Open access
Semantic Scholar
Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.
Samuel Janssen, Carsten M Jakobsen, D. Rosen, Rebecca M. Ricklis +4 more
2004Molecular Cancer Therapeutics43 citations
Semantic Scholar
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.
J. Karp, K. Flatten, Eric J. Feldman, J. Greer +18 more
2009Blood20 citations Open access
Semantic Scholar
A rapid and sensitive method for determination of veliparib (ABT-888) in human plasma, bone marrow cells and supernatant by using LC/MS/MS
Sarah E. Reinhardt, Ming Zhao, A. Mnatsakanyan, Linping Xu +4 more
2009Journal of Pharmaceutical and Biomedical Analysis10 citations Open access
Semantic Scholar
Phase I dose‐escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias
Abeer Abd Elmoneim, L. Gore, Rebecca M. Ricklis, Jessica Boklan +5 more
2012Pediatric Blood & Cancer9 citations
Semantic Scholar
Phase 1 Dose- Escalation Trial of Clofarabine Followed by Escalating Dose of Fractionated Cyclophosphamide in Adults with Relapsed or Refractory Acute Leukaemias
A. Zeidan, Rebecca M. Ricklis, H. Carraway, H. D. Yun +9 more
2012British Journal of Haematology9 citations Open access
Semantic Scholar
In Vivo Correlates of Response for Phase I Trial of Oral Tipifarnib (T) Combined with Oral Etoposide (E) for Adults Age ≥ 70 with Newly Diagnosed Acute Myelogenous Leukemia (AML) Who Are Not Candidates for Traditional Cytotoxic Chemotherapy (TCC).
Rebecca M. Ricklis, J. Karp, E. Feldman, S. Galkin +7 more
20075 citations
Semantic Scholar
Phase I Clinical-Laboratory Trial of Clofarabine (CLO) Followed by Cyclophosphamide (CY) for Adults with Refractory Acute Leukemias: Evidence for Enhanced DNA Damage.
J. Karp, Rebecca M. Ricklis, J. Greer, Janet Briel +1 more
20062 citations
Semantic Scholar
cyclophosphamide for adults with refractory acute leukemias A phase 1 clinical-laboratory study of clofarabine followed by
B. D. Smith, Michael A. Mcdevitt, H. Carraway, M. Levis +6 more
20130 citations
Semantic Scholar
Abstract 4539: Anti-leukemic activity of mitochondria-targeted asymmetrical 2,2′-binaphthoquinones
Rebecca M. Ricklis, Milena Vuica-Ross, R. Brodsky, E. Sausville +3 more
20100 citations
Semantic Scholar
Anti-Leukemic Activity of Mitochondrially-Directed Asymmetrical 2-2'-Binaphthoquinones.
Rebecca M. Ricklis, Milena Vuica-Ross, R. Brodsky, E. Sausville +3 more
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Greer×7
Invite
J. Greer — researcher profile on SciRah
J. Karp×7
Invite
J. Karp — researcher profile on SciRah
S. Denmeade×4
Invite
S. Denmeade — researcher profile on SciRah
J. Karp×4
Invite
J. Karp — researcher profile on SciRah

×3

Invite

D. Rosen — researcher profile on SciRah

Invite

Janet Briel — researcher profile on SciRah

Invite

S. D. Gore — researcher profile on SciRah

Michael A. Mcdevitt×3

Invite

Michael A. Mcdevitt — researcher profile on SciRah

Invite

H. Carraway — researcher profile on SciRah

Mark J. Levis×3

Invite

Mark J. Levis — researcher profile on SciRah

Valerie Ironside×3

Invite

Valerie Ironside — researcher profile on SciRah

Invite

M. Levis — researcher profile on SciRah